ClinicalTrials.gg
RecruitingNCT03914807CoMFORTUpdated Dec 13, 2023

Cow Milk Fat Obesity pRevention Trial

An interventional study of Whole (3.25%) cow's milk recommendation and Reduced (1%) fat milk in Obesity, Childhood, sponsored by The Hospital for Sick Children. Recruiting at 1 site in Canada. Open to participants aged 18 Months to 60 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-13.

Sponsored by The Hospital for Sick Children · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Jan 2020; still recruiting 6 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
534
Allocation
Randomized
Ages
18 Months to 60 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Pediatric Obesity by The Hospital for Sick Children — 2 open to participants now, 2 under way, none of them phase 3. Pediatric Obesity · The Hospital for Sick Children.

Planned enrollment
3rd of 11
534 · median 99
Started
2020
the only one that year
No phase
10 of 14
2 open now
Registered
8th of 14
by date

Among the 14 studies in Pediatric Obesity by The Hospital for Sick Children, this one is the 3rd largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2020, is one of 10 with no phase, and was the 8th registered.

Pediatric Obesity

1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.

Browse Pediatric Obesity studies →

Open to participants now

2 of the 14 studies in Pediatric Obesity by The Hospital for Sick Children are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 119 Pediatric Obesity studies recruiting now, 16 (13%) set no upper age limit and 101 (85%) stop at 75 or younger; 110 take children under 18; 67 take healthy volunteers.

This study: 18 Months to 60 Months · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Pediatric Obesity by The Hospital for Sick Children, or all of them as a file.
02

Study summary

Cow's milk is a dietary staple for children in North America. Though clinical guidelines suggest children transition from whole (3.25% fat) milk to reduced (1%) fat milk at age 2 years, recent epidemiological evidence supports a link between whole milk consumption and lower adiposity in children. The purpose of this trial is to determine which milk fat recommendation minimizes excess adiposity and optimizes child nutrition and development. CoMFORT will be a parallel group randomized controlled trial among children aged 2 to 4 years participating in the TARGet Kids! practice-based research network. Children will be randomized to receive one of two usual care nutritional recommendations: 1) a recommendation to consume whole milk, or 2) a recommendation to consume reduced (1%) fat milk. The primary outcome is Body Mass Index z-score (zBMI); secondary outcomes will be cognitive development (using the Ages and Stages Questionnaire), vitamin D stores (serum 25-hydroxyvitamin D), cardiometabolic health (glucose, hsCRP, non-HDL, LDL, triglyceride, HDL and total cholesterol, insulin, and diastolic and systolic blood pressure) and sugar sweetened beverage intake (measured by 24-hour dietary recall). Outcomes will be measured 24 months post-randomization and compared using ANCOVA, adjusting for baseline measures. This trial will contribute to nutrition policy for children in effort to reduce childhood obesity using a simple, inexpensive and scalable cow's milk fat intervention.

03

Conditions studied

  • Obesity, Childhood

Browse trials for

Keywords

  • milk
  • fat
  • cohort-embedded
04

Who can participate

Ages eligible
18 Months to 60 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy by parental report;
  • 1.5 to 2.99 years of age
  • involved in a TARGet Kids! academic pediatric or family medicine group.

Exclusion criteria

Exclusion Criteria:

  • Prader-Willi syndrome or other syndrome associated with obesity
  • severe development delay
  • children who are from families without verbal communication in English or French
  • failure to thrive (with zBMI values ≤ -2 are unlikely to benefit from obesity prevention)
  • siblings of trial participants as families may share milk
  • will not consume cow's milk by choice, lactose intolerance or allergy.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
534 participants (estimated)

Study arms

  • Active comparator
    Whole (3.25%) milk

    Other: Whole (3.25%) cow's milk recommendation

  • Active comparator
    Reduced fat (1%) milk

    Other: Reduced (1%) fat milk

Interventions

  • OtherWhole (3.25%) cow's milk recommendation

    Children randomized to the whole milk recommendation will receive a recommendation a primary care recommendation to consume 500 mL of whole fat (3.25%) milk instead of transitioning to reduced fat (1%) milk at 2 years of age. The primary care physician will verbally make this recommendation during the recruitment well-child visit. Parents will also be reminded bi-monthly by phone calls made by a research assistant. Children in the whole milk recommendation group will be provided with the same age-appropriate nutritional recommendations as children in the reduced fat recommendation group as part of routine healthcare according to the Rourke Baby Record.

  • OtherReduced (1%) fat milk

    Children randomized to the reduced fat group will receive a primary care recommendation to transition from whole milk to 500 mL reduced fat (1%) milk daily once the child is two years of age (consistent with current guidelines). The physician will verbally make this recommendation during the recruitment well-child visit. Parents will also be reminded bi-monthly by phone calls made by a research assistant. Children who receive the reduced fat recommendation will be provided with the same age-appropriate nutritional recommendations as children who receive the whole fat recommendation as part of routine healthcare according to the Rourke Baby Record.

06

What researchers measure

Primary outcomes

  1. weight

    kilograms; measured using a Healthometer stadiometer

    Time frame: Measured 24 months post-study entry

  2. height

    metres; measured using a Healthometer statiometer

    Time frame: Measured 24 months post-study entry

  3. body mass index z-score (zBMI)

    BMI calculated by weight (kg)/height (m\^2); zBMI determined according to the World Health Organization guidelines

    Time frame: Measured 24 months post-study entry

Secondary outcomes

  1. serum 25-hydroxyvitamin D

    measured in nmol/L

    Time frame: Measured 24 months post-study entry

  2. serum glucose

    measured in mmol/L

    Time frame: measured 24 months post-study entry

  3. blood pressure

    systolic and diastolic

    Time frame: measured 24 months post-study entry

  4. serum insulin

    measured in mmol/L

    Time frame: measured 24 months post-study entry

  5. serum triglycerides

    measured in mmol/L

    Time frame: measured 24 months post-study entry

  6. serum total cholesterol

    measured in mmol/L

    Time frame: measured 24 months post-study entry

  7. serum high density lipoprotein cholesterol

    measured in mmol/L

    Time frame: measured 24 months post-study entry

  8. serum low density lipoprotein cholesterol

    measured in mmol/L

    Time frame: measured 24 months post-study entry

  9. serum non-high density lipoprotein cholesterol

    measured in mmol/L

    Time frame: measured 24 months post-study entry

  10. serum highly sensitive c-reactive protein

    measured in mg/L

    Time frame: measured 24 months post-study entry

  11. height z-score

    measured by a trained research assistant according to the World Health Organization guidelines

    Time frame: measured 24 months post-study entry

  12. waist circumference

    measured by a trained research assistant

    Time frame: measured 24 months post-study entry

  13. lean body mass

    measured in kg, % body weight

    Time frame: measured 24 months post-study entry

  14. fat mass

    measured in kg, % body weight

    Time frame: measured 24 months post-study entry

  15. school readiness

    measured using the Early Development Instrument (EDI); children scoring at or below the 25th percentile of children in their province are considered at risk for continuing on the low achievement and health trajectory, and are more likely to fall behind in academic achievement in later grades

    Time frame: measured 24 months post-study entry

  16. cognitive development

    measured using the Ages and Stages Questionnaire (ASQ)

    Time frame: measured 24 months post-study entry

  17. dietary intake

    measured using the Automated Multiple Pass Self Administered 24 hour recall (ASA24) tool

    Time frame: measured 24 months post-study entry

  18. carotid intima media thickness (cIMT)

    measured by ultrasound

    Time frame: measured 24 months post-study entry

  19. restrained and emotional eating

    measured using the 3-factor eating questionnaire

    Time frame: measured 24 months post-study entry

  20. nutritional risk

    measured using NutriSTEP preschooler

    Time frame: measured 24 months post-study entry

  21. physical activity (minutes per day)

    questionnaire data and accelerometry

    Time frame: measured 24 months post-study entry

  22. sleep time (hours per night)

    questionnaire data and accelerometry

    Time frame: measured 24 months post-study entry

  23. healthcare service utilization

    information accessed through OHIP linkage

    Time frame: measured 24 months post-study entry

  24. upper respiratory tract infection incidence

    information accessed through OHIP linkage

    Time frame: measured 24 months post-study entry

  25. growth trajectories

    zBMI growth rates

    Time frame: measured 24 months post-study entry

  26. head circumference

    measured by a trained research assistant

    Time frame: measured 24 months post-study entry

  27. cost effectiveness

    All costs, parameter estimates and ranges will be derived from study data and will be obtained using medical record extraction. Publicly available Ontario costing sources will be used to cost resource utilisation parameters.

    Time frame: measured 24 months post-study entry

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Vanderhout SM, Aglipay M, Birken C, Li P, O'Connor DL, Thorpe K, Constantin E, Davis MA, Feldman M, Ball GDC, Janus M, Juni P, Junker A, Laupacis A, L'Abbe M, Manson H, Moretti ME, Persaud N, Omand JA, Relton C, Wong P, Yamashiro H, Tavares E, Weir S, Maguire JL. Cow's Milk Fat Obesity pRevention Trial (CoMFORT): a primary care embedded randomised controlled trial protocol to determine the effect of cow's milk fat on child adiposity. BMJ Open. 2020 May 7;10(5):e035241. doi: 10.1136/bmjopen-2019-035241. PubMed 32385063 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2020 (actual). Primary completion is estimated for Dec 2024, 59 months after the start.

Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 59 months is above that.

Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 10, 2019
First posted
Apr 16, 2019
StartActual
Jan 1, 2020
Primary completionEst.
Dec 1, 2024
CompletionEst.
Jun 1, 2025
Last update
Dec 13, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03914807
Responsible party
Jonathon L Maguire (Principal Investigator, The Hospital for Sick Children) — Principal investigator
First posted
Apr 16, 2019
Start date
Jan 1, 2020
Primary completion
Dec 1, 2024 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
Dec 13, 2023

Study contacts

Jonathon L Maguire, MD, FRCPC
Contact
jonathon.maguire@utoronto.ca
(416) 867-3655
Jonathon L Maguire, MD, FRCPC
principal investigator · Unity Health Toronto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion